Background The increasing number of patients treated by long-term non-invasive ventilation (NIV) challenges the capacity of ...
The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.
Registry analysis suggests endoscopic lung volume reduction yields similar physiologic gains across sexes, but women report ...
1 Mayo Clinic, Division of Cardiovascular Diseases, Scottsdale, AZ, United States 2 Mayo Clinic, Division of Cardiovascular Diseases, Rochester, MN, United States Introduction: The lingering ...
CoStar Group locating one of their headquarters in Richmond has had a significant impact on the local economy and the city skyline. Knock-on effects in the local arts scene may be more subtle but no ...
Measuring lung function earlier in life would help identify people at risk of developing chronic obstructive pulmonary disease (COPD) and allow for more timely interventions, according to a new study ...
aDepartment of Medicine, Division of Allergy and Immunology, National Jewish Health, 1400 Jackson Street, Denver, CO 80206, USA bDepartment of Pediatrics, Division of Allergy and Immunology, National ...
The lung tissue of people with chronic obstructive pulmonary disease contains triple the sootlike particle buildup found in similar tissue in smokers’ lungs, a recent analysis finds. The study found ...
The combined actions of elastin, collagen and surface tension, along with a supporting network of muscles and connective tissues, create lung capacity. This is the total volume of air in the lungs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback